Skip to main content

Table 4 Visits and time points

From: The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial

Baseline period Within 28 days before randomization
Visit 1 Day 0 (up to 7 days after randomization)
Visit 2 Day 7 (±2 days)
Telephone visits 1 to 9 Weeks 4, 8, 16, 20, 28, 32, 40, 44 and 48 (±7 days)
Visits 3 to 5 Weeks 12, 24 and 36 (±7 days)
Visit 6 Week 52 (±7 days) or shortly after close-out